Amra (Mango): Traditional Uses, Leaf-Extract Research & Safety
TL;DR
Amra is mango, Mangifera indica. The fruit is food; the medicine is a manufactured leaf extract. Traditional uses rest on tradition and animal studies. Three small human crossover studies: two found acute attention and mood gains with 100–150 mg soluble leaf extract in young adults; a third found no significant benefit from 300 mg. Promising. Narrow.
What it is
Amra is the mango tree, Mangifera indica L.: a large evergreen in the cashew family (Anacardiaceae), native to South Asia and now grown across the tropics. Its fruit (aam) is one of the most widely consumed tropical fruits on earth (phytochemical/pharmacological review).
The medicinal parts are not the ripe fruit. They are the bark, leaves, flowers, and seed kernel, each with distinct uses (same review). The signature compound in the leaves is mangiferin, a xanthone glycoside studied for antioxidant and anti-inflammatory activity (same review). When the trials below say "mango leaf extract," they mean concentrated mangiferin. Not leaves in tea.
Traditional use
Ayurvedic and folk tradition attributes astringent, cooling properties to mango bark and leaves, using them for diarrhea, dysentery, wounds, ulcers, hemorrhage, and hemorrhoids. Leaf decoctions are a traditional remedy for diabetes and "blood pressure." The seed kernel is used for chronic diarrhea, hemorrhage, and diabetes. The ripe fruit is considered tonic, laxative, and refreshing (Pharmacognosy Reviews; phytochemical/pharmacological review).
Mango leaves and twigs also play a ritual role in Hindu worship (ethnobotanical survey). None of this is clinical proof. I want that sentence sitting right next to the list, because the human-trial evidence gets assessed separately below.
What modern research says
Cognition and mood: two crossover trials of a standardized leaf extract
Here is what the human trials actually tested, and what they did not. They tested manufactured mango leaf extracts: the standard Zynamite extract (a 300 mg single dose in one 114-person crossover trial (Dodd et al., Frontiers in Nutrition 2024; PubMed PMID 38665302)) and the soluble Zynamite S formulation (single 100–150 mg doses in later trials), all standardized to at least 60% mangiferin. Not mango fruit. Not brewed leaves. Not generic powder. The distinction is everything.
One earlier 114-person crossover trial of the standard 300 mg extract, though, found no benefit: no significant improvement in cognitive performance or mood versus placebo at up to 300 minutes post-dose: the only significant difference was an increase in subtraction errors on the cognitive-demand battery (Dodd et al., Frontiers in Nutrition 2024; PubMed PMID 38665302).
The first trial I want you to know about was a randomized, double-blind, placebo-controlled crossover trial in 119 university students. A single 100 mg or 150 mg dose of the extract improved processing speed and cognitive flexibility and reduced tension, depression, and confusion scores versus placebo, with effects measured from 30 minutes to 5 hours after intake. Short- and long-term verbal memory did not improve. I report the negative result because it matters (Castellote-Caballero et al., Pharmaceuticals 2025; PubMed PMID 40284006).
Then a 2026 replication trial (randomized, double-blind, placebo-controlled crossover, n=88 healthy young adults) reproduced the acute benefits of a single 100 mg dose: significant improvements in mental processing speed, attention, cognitive flexibility, and mood versus placebo over a 5-hour window (Pharmaceuticals 2026).
My judgment: promising, not conclusive. Two honest caveats come straight from the literature. The replication was conducted by the same research group and facility, an internal replication rather than an independent one. And the studies involved the extract's manufacturer, Nektium Pharma (same paper). Effects were acute and single-dose. There are no data on daily long-term use. Small, short, manufacturer-involved: that is the shape of this evidence.
Everything else: preclinical only
A 2010 review catalogues a long list of reported activities: antidiabetic, antioxidant, anti-inflammatory, antimicrobial, cardioprotective, and more. But it notes these come from animal and laboratory studies, and it explicitly calls for clinical trials to be conducted (Pharmacognosy Reviews).
Sixteen years later, that call is still unanswered. There are still no published human trials testing mango leaf, bark, or seed for diabetes, blood pressure, diarrhea, or wound healing. Traditional uses for those conditions remain unproven in people. I state this flatly because it is the most important sentence in this section.
Dosage
There is no established personal dose. What exists are research doses from the cognition trials: a single 300 mg dose of the standard extract in one trial (Dodd et al., Frontiers in Nutrition 2024; PubMed PMID 38665302), the trial that found no significant benefit, and single 100–150 mg doses of the proprietary soluble leaf extract (Zynamite S, 60% mangiferin or more) in later trials (PubMed PMID 40284006).
Read that carefully. A research dose of a specific manufactured extract: not a personal recommendation, and not interchangeable with mango fruit, leaf tea, or generic powder. No pharmacopoeial or trial-based dose exists for amra bark, leaf decoctions, or seed preparations.
Safety & contraindications
Ripe mango fruit is eaten as food worldwide without general safety concerns. The medicinal parts are a different matter, and I would not conflate the two.
Mango peel and the plant's sap can trigger contact dermatitis in sensitive individuals. Cross-sensitization from prior poison-ivy or poison-oak exposure is documented in a clinical case report (mango dermatitis case report, UC Irvine). One review notes rare allergic skin reactions linked to leaf constituents (mango-leaf review).
In animal models, very high doses of leaf compounds caused mild, reversible liver and kidney stress. Animal data only, but a reason not to assume concentrated extracts are harmless (same review).
There are no dedicated long-term human safety trials of mango-leaf extracts, and no safety data for pregnancy or breastfeeding. People with mango or cashew-family allergies should be cautious. As always, consult a clinician before using medicinal preparations.
FAQs
Is mango leaf good for diabetes?
Traditionally, yes. Leaf decoctions are a folk remedy for diabetes. But no human trial has tested mango leaf for blood sugar, and the reported antidiabetic effects come only from animal and laboratory studies (Pharmacognosy Reviews). It is not a proven diabetes treatment. A folk remedy is not a synonym for medicine.
Does mango leaf extract improve focus?
Two small crossover trials say maybe. A single 100–150 mg dose of a standardized soluble extract (60% mangiferin) acutely improved attention, processing speed, and mood in healthy young adults versus placebo (PubMed PMID 40284006; Pharmaceuticals 2026). Small, short, single-dose, and the extract's manufacturer was involved. Promising, not conclusive.
Can I just eat mangoes for these benefits?
No, and I want to be blunt about it, because this is the most common misreading of these studies. The trials tested a concentrated, solubility-enhanced leaf extract, not the fruit. Eating mangoes gives you a nutritious fruit. It does not give you the studied intervention.
What is amra used for in Ayurveda?
Traditionally the bark, leaves, and seed for diarrhea, dysentery, wounds, hemorrhage, and diabetes; the ripe fruit as a tonic and laxative (Pharmacognosy Reviews). Traditional uses, not clinically proven effects.
Is mango safe during pregnancy?
Ripe mango eaten as food is a normal part of diets worldwide. Medicinal preparations of mango leaf, bark, or seed have no pregnancy safety data and should be avoided without medical advice. Food and medicine are different categories here.
Can mango cause allergies?
Yes, in some people. The peel and sap can cause contact dermatitis, particularly in those with prior poison-ivy or poison-oak sensitization (mango dermatitis case report, UC Irvine), and rare allergic skin reactions to leaf constituents have been reported (mango-leaf review). Poison ivy is a family relative. The allergy connection is a family trait.
Sources
The traditional-use catalogue and the preclinical-activity list come from Shah et al.'s 2010 "Mangifera indica (mango)" review in Pharmacognosy Reviews (PubMed), the paper that also, sixteen years ago, called for the clinical trials that still have not arrived. The cognition trials are Castellote-Caballero et al. 2025 on soluble mango leaf extract (Zynamite S), Pharmaceuticals 18(4):571 (PubMed PMID 40284006), and the 2026 replication trial in the same research program, Pharmaceuticals 19:1112 (MDPI), the paper that discloses both the same-group replication and the manufacturer's involvement. The phytochemical background draws on the human-journals review of Mangifera indica (PDF). The ritual use of mango leaves and twigs is from an ethnobotanical survey (PDF). The dermatitis warning rests on a UC Irvine emergency-medicine case report on mango dermatitis after urushiol sensitization (eScholarship), and the leaf-safety notes come from the 2025 mango-leaf review in the Journal of Pharmacognosy and Phytochemistry (PDF).
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.